S 2345 · in committee · significant
Short on Competition Act
- healthcare
What this bill does
- The FDA must allow temporary imports of prescription drugs facing shortages or limited competition.
- Patients needing life-saving or life-sustaining medications are affected when domestic supply is scarce.
- The import authority lasts three years or until the shortage ends, whichever comes first.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would temporarily allowing prescription drug imports affect domestic pharmaceutical manufacturers' ability to invest in new drug development?
- 02
What safeguards would distinguish imported drugs as safe and effective compared to FDA-approved domestic medications?
- 03
Which patient populations would benefit most from this import authority, and could shortages be resolved through other supply-chain interventions?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · D-MN
Amy Klobuchar
Citizen cosponsors
0
In Congress
3/ 100
Senators cosponsoring
Introduced 2025-07-17
Joining the bill
Legislative timeline
2025-07-17 · senate · IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2025-07-17 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.